Alzheimer’s treatment : lecanemab soon on sale in the United States
On January 6th, the United States health authority (FDA) authorized the marketing of lecanemab, a new anti-Alzheimer’s drug, the latest results of which were revealed last November. Finally an effective Alzheimer’s treatment on the market ? This is the question that everyone is asking when this agreement is announced.
…Alzheimer’s treatment : lecanemab soon on sale in the United StatesRead More »